---
title: "NMN | EH301 - Elysium Basis"
url: "/alternative-treatments/eh301"
summary: Nicotinamide mononucleotide and Nicotinamide Riboside
tags:
- supplements
date: "2020-05-09T00:00:00Z"

image:
  caption:
  focal_point: Smart
  
authors: 

# links:
# - icon: twitter
#   icon_pack: fab
#   name: Follow
#   url: https://twitter.com/georgecushen
# url_code: ""
# url_pdf: ""
# url_slides: ""
# url_video: ""

# Slides (optional).
#   Associate this project with Markdown slides.
#   Simply enter your slide deck's filename without extension.
#   E.g. `slides = "example-slides"` references `content/slides/example-slides.md`.
#   Otherwise, set `slides = ""`.
# slides: example

---
## Science

What are NMN and NR?
Nicotinamide mononucleotide (NMN)
NR (Nicotinamide Riboside) 


## Articles
#### NMN
* [NMN as a potential therapeutic agent for muscle disease](https://www.nmn.com/news/nmn-as-potential-therapeutic-agent-for-muscle-disease)
* [Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)](https://www.ncbi.nlm.nih.gov/pubmed/27002158)

#### EH301 - Elysium Health Basis (patented NR + PT (pterostilbene) )
* 19 Feb 2019 - [University of Valencia Research Reveals that eH301 May Halt ALS Progression](https://www.trialsitenews.com/university-of-valencia-research-reveals-that-eh301-may-halt-als-progression/)
* 18 Feb 2019 - [In Small Trial, EH301 Appears to Halt Progression of ALS](https://www.alzforum.org/news/research-news/small-trial-eh301-appears-halt-progression-als)
* **PDF - Jan 2019** - [Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study](./eh301_study.pdf)
* 3 Apr 2018 - [Elysium Healthâ€™s EH301 Designated Orphan Drug by FDA for Treatment of ALS](https://alsnewstoday.com/2018/04/03/eh301-granted-orphan-drug-designation-amyotrophic-lateral-sclerosis/)
 
  

